Kohjin Bio Co (TSE:177A) Total Equity: 円5,945 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:177A Kohjin Bio Co Ltd TSE:177A
17 GF Score
Price 円860.00
! 3 Warning Signs
View Full Analysis

What is Kohjin Bio Co Total Equity?

Kohjin Bio Co TSE:177A -1.15% 17 Total Equity is 円5,945 Mil as of Mar. 2026. GuruFocus rates TSE:177A with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Kohjin Bio Co's total equity for the quarter that ended in Mar. 2026 was 円5,945 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Kohjin Bio Co Total Equity Historical Data

* Premium members only.

The historical data trend for Kohjin Bio Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co Total Equity Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
2,216.89 3,017.83 3,342.39 5,781.82 5,945.18

Kohjin Bio Co Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Equity Get a 7-Day Free Trial 3,342.39 5,279.42 5,781.82 5,813.18 5,945.18
TSE:177A
17GF Score
Kohjin Bio Co Ltd TSE:177A
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kohjin Bio Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Kohjin Bio Co's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=8904.397-2959.219
=5,945

Kohjin Bio Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=8904.397-2959.219
=5,945

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円5,945 Mil mean?
Kohjin Bio Co (TSE:177A) has a Total Equity of 円5,945 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Kohjin Bio Co and its competitors.
Is Kohjin Bio Co's Total Equity too high?
Kohjin Bio Co's current Total Equity is 円5,945 Mil. Overall, Kohjin Bio Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Total Equity compare to VRTX and REGN?
Kohjin Bio Co's Total Equity of 円5,945 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Kohjin Bio Co and its competitors. Kohjin Bio Co's current Total Equity is 円5,945 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Total Equity of 円5,945 Mil. The current Total Equity is 円5,945 Mil. Kohjin Bio Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Total Equity is 円5,945 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kohjin Bio Co Business Description

Address 5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
17GF Score

Get the complete analysis for TSE:177A

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円860.00
Price